Skip to main content

Animations

MJFF Publications

581 - 590 of 8404 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    RESTRICTED
    Title: An interpretable deep learning Bayesian optimized random forest framework for the diagnosis of Parkinson's disease in structural magnetic resonance images
    Journal Name: International Journal of Imaging Systems and Technology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ima.23106
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: ePresentations
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.16338
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-024-02937-4
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Alpha-synuclein aggregates are phosphatase resistant
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-024-01785-0
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-49016-3
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Neuroprotective Strategies and Cell-Based Biomarkers for Manganese-Induced Toxicity in Human Neuroblastoma (SH-SY5Y) Cells
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom14060647
    Best OA location URL:
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of Outcome
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.14089
    Citation Count: 3
  • Summary Details
    OPEN
    Title: High-Yield α-Synuclein Purification and Ionic Strength Modification Pivotal to Seed Amplification Assay Performance and Reproducibility
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms25115988
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Digital outcome measures from smartwatch data relate to non-motor features of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00719-w
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Dysregulated Wnt and NFAT signaling in a Parkinson’s disease LRRK2 G2019S knock-in model
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-63130-8
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.